Chronus Health offers a portable diagnostic platform that utilizes proprietary electrical sensing, microfluidics, and machine learning to perform multi-analyte blood tests with results available in 15 minutes. This technology eliminates the need for sample preparation and trained technicians, making point-of-care testing more accessible and cost-effective for various clinical environments.
Funding
$27.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current point-of-care blood testing solutions often require extensive sample preparation, trained technicians, and expensive equipment, limiting accessibility and increasing costs in various clinical settings. Existing platforms may also lack the ability to perform multi-analyte testing on a single platform, hindering comprehensive clinical decision-making.
Solution
Chronus Health offers a point-of-care diagnostic platform that enables rapid, multi-analyte blood testing without the need for sample preparation or trained personnel. The platform utilizes proprietary electrical sensing technology combined with microfluidics, aptamers, and machine learning to deliver results in approximately 15 minutes. This innovative approach allows for the simultaneous detection of cells, electrolytes, small molecules, and proteins from a whole blood sample. The modular system is designed to fit various clinical environments, providing low-cost and accessible blood testing capabilities.
Target Audience
The primary target audience includes urgent cares, infusion clinics, skilled nursing facilities, retail clinics, and primary care providers seeking accessible and cost-effective point-of-care blood testing solutions.
Features
- Multi-analyte testing for cell assays, chemistry, and immunoassays on a single platform
- Electrical detection using aptamers and proprietary chemistry
- No sample preparation required; utilizes whole blood
- CLIA-waived operation, eliminating the need for trained lab technicians
- Modular platform design for increased test throughput
- Single-use cartridge containing microfluidic sensor, buffer, and reagent
- Label-free CBC analysis without plasma separation or monolayer reagent
- Electrochemical aptamer-based protein assay for higher specificity and reliability